Valneva Announces Investor Day to Showcase Vaccine Pipeline
Company Announcements

Valneva Announces Investor Day to Showcase Vaccine Pipeline

Valneva (VALN) has released an update.

Valneva SE, a specialty vaccine company, has announced an Investor Day event to be held in New York on October 10, 2024, focusing on its innovative vaccine candidates for Lyme disease, Shigella, and Zika, as well as its commercial vaccine portfolio, including the only approved chikungunya vaccine. The event, which includes a live Q&A session with company executives, will be available both in person and via webcast. The company’s ongoing work is fueled by revenues from its commercial vaccines, with the goal of addressing significant unmet medical needs in infectious diseases.

For further insights into VALN stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskValneva SE Reports Profitable Nine-Month Performance
TipRanks Auto-Generated NewsdeskValneva Reports Profitable Quarter Amid Vaccine Launches
TipRanks Auto-Generated NewsdeskValneva’s Chikungunya Vaccine Gains Scientific Spotlight
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App